Objective: The aim of this study is to evaluate maternal & fetal outcome in cases of renal transplant patients.
INTRODUCTION
As fertility can be restored to normal soon after renal transplant, it is important for physicians caring for recipients to inform the patient about the potential risks of pregnancy. Pregnant recipients should be managed in close conjunction with a nephrologist. It is important to recognize that regular menses and fertility are usually restored shortly after successful transplantation and has been reported as early as 3 weeks post-transplant (1, 2) . In a study data of United States Renal Data System (USRDS), from 1990 to 2003, Gill et al. estimated a pregnancy rate of 33 per thousand (3.3%) in female kidney transplant recipients of child bearing age in the first 3 years posttransplant (3). Of these pregnancies, only 55.4% ended in a live birth. In contrast, the National Transplantation Pregnancy Registry (NTPR) and the UK transplant pregnancy registry reported much higher live birth rates of 75-80 %. In the USRDS data the outcomes of spontaneous and therapeutic abortion were 21.2% and 3.8% respectively (3).
Criteria for considering pregnancy in renal transplanted patients include good post-transplant health for 2 years, stable allograft function with a serum creatinine < 1.5 mg/dl, absence of rejection, control of blood pressure, absence of proteinuria (<0.50 g/dl), and normal allograft ultrasound. All of the medications used in posttransplant immunosuppressive regimens cross the placenta and expose the foetus to potential toxicities (4, 5) . Effect of these medications on the foetus is difficult to determine because of the lack of controlled trials on drug safety in pregnancy (4). Pre-existing kidney disease is an independent risk factor for preeclampsia, diabetes mellitus, various opportunistic infections, anemia, prematurity, low birth weight, and neonatal death (6, 7) . Safety of breastfeeding by mothers receiving immunosuppressant remains uncertain because of passage of medications into breast milk and the unknown neonatal exposure. The aim of this study is to evaluate maternal & fetal outcome in cases of renal transplant patients.
MATERIAL & METHODS
This is a retrospective study from 2010 to 2012 at a tertiary care centre. We analyzed 6 pregnancies in 5 renal transplant recipients. The studied parameters included transplantationpregnancy interval, presence of hypertension prior to pregnancy, new onset hypertension, worsening hypertension, new onset proteinuria, urinary tract infection, gestational age, and mode of delivery, foetal outcome, renal graft function before, during and after pregnancy, and immunosuppressive toxicities. During the pregnancy patients were examined monthly in renal transplant outpatient department to monitor arterial hypertension, serum creatinine, complete blood count, proteinuria, side effects of immunosuppressive drugs and treatment.
RESULTS
In our study, the mean age was 28.6±3 years. The mean time interval between renal transplantation & pregnancy was 2 years & 7months.All patients had stable allograft function with absence of rejection, normal allograft ultrasound absence of proteinuria.
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Original PaPer (8, 9 , and 10). MPA products and Sirolimus are to be avoided and discontinued 6 weeks prior to a planned pregnancy (11, 12, and 13) .
Hypertension
and Preeclampsia developed in 50% of pregnant renal transplant recipients compared to Original PaPer www.slcog.lk/sljog only 5-8% in general population (8, 11 and 14) . Alpha methyl dopa is considered the drug of choice because of its well documented safety and lack of teratogenicity. Caesarean section was performed in 28.5% patient. The high rate of caesarean section may be explained by obstetrical indications or the fact that it is a precious pregnancy. If a caesarean delivery is performed, attention should be paid to the course of the transplanted ureter, which runs between the transplanted kidney and the bladder.
CONCLUSION
Pregnancy in a renal transplant recipient is high risk and should be comanaged by a high risk obstetrician, specifically one with experience in caring for patients with renal dysfunction (11, 15) . Pregnancy in renal transplanted patient can be carried out under optimal circumstances, including stable allograft function for at least 1 year post transplant without rejection, good control of blood pressure, and appropriate adjustment of immunosuppressant and other known teratogenic medications prior to conception. With close medical and obstetric follow up, successful outcome for both the mother and the infant is possible. Patient to be counseled and to be given best available information about conception and child bearing in these cases, there is fifty percent chance that mother will be dead before the child celebrates 15th birthday. ■
